130 related articles for article (PubMed ID: 31743207)
1. Pennywise and a Pound Foolish: The Advantage of Dantrolene Nanosuspension (Ryanodex) in the Treatment of Malignant Hyperthermia.
McAvoy JC; Brodsky JB; Brock-Utne J
Anesth Analg; 2019 Dec; 129(6):e201-e202. PubMed ID: 31743207
[No Abstract] [Full Text] [Related]
2. Dantrolene Should Be Readily Available Wherever Malignant Hyperthermia Triggering Drugs Are Stocked.
Larach MG; Riazi S; Rosenberg H
Anesth Analg; 2019 Nov; 129(5):e175-e176. PubMed ID: 31478931
[No Abstract] [Full Text] [Related]
3. Donating Dantrolene: Development and Implementation of a Malignant Hyperthermia Program in a Scarce Resource Setting.
Smith A; Brandom B; Miner L; Henker R
AANA J; 2022 Aug; 90(4):271-277. PubMed ID: 35943752
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of stocking dantrolene in ambulatory surgery centers for the treatment of malignant hyperthermia.
Aderibigbe T; Lang BH; Rosenberg H; Chen Q; Li G
Anesthesiology; 2014 Jun; 120(6):1333-8. PubMed ID: 24714119
[TBL] [Abstract][Full Text] [Related]
5. [S1 guidelines on malignant hyperthermia : Update 2018].
Wappler F
Anaesthesist; 2018 Jul; 67(7):529-532. PubMed ID: 29943228
[TBL] [Abstract][Full Text] [Related]
6. Malignant Hyperthermia-Susceptible Adult Patient and Ambulatory Surgery Center: Society for Ambulatory Anesthesia and Ambulatory Surgical Care Committee of the American Society of Anesthesiologists Position Statement.
Urman RD; Rajan N; Belani K; Gayer S; Joshi GP
Anesth Analg; 2019 Aug; 129(2):347-349. PubMed ID: 31166228
[TBL] [Abstract][Full Text] [Related]
7. Malignant hyperthermia in an office surgery suite: a case report.
Turpin IM; Manino J
Aesthetic Plast Surg; 1989; 13(2):121-3. PubMed ID: 2741752
[TBL] [Abstract][Full Text] [Related]
8. Ryanodex--A New Dantrolene Formulation for Malignant Hyperthermia.
Med Lett Drugs Ther; 2015 Jul; 57(1472):100. PubMed ID: 26147894
[No Abstract] [Full Text] [Related]
9. In Response.
Urman RD; Rajan N; Belani K; Gayer S; Joshi GP
Anesth Analg; 2019 Dec; 129(6):e202. PubMed ID: 31743208
[No Abstract] [Full Text] [Related]
10. Cost-benefit Analysis of Maintaining a Fully Stocked Malignant Hyperthermia Cart versus an Initial Dantrolene Treatment Dose for Maternity Units.
Ho PT; Carvalho B; Sun EC; Macario A; Riley ET
Anesthesiology; 2018 Aug; 129(2):249-259. PubMed ID: 29672336
[TBL] [Abstract][Full Text] [Related]
11. Malignant hyperthermia in the ambulatory surgery center: how should we prepare?
Litman RS; Joshi GP
Anesthesiology; 2014 Jun; 120(6):1306-8. PubMed ID: 24710219
[No Abstract] [Full Text] [Related]
12. [Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
Schuster F; Johannsen S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):549-558. PubMed ID: 31525788
[TBL] [Abstract][Full Text] [Related]
13. Successful use of dantrolene sodium in human malignant hyperthermia syndrome: a case report.
Friesen CM; Brodsky JB; Dillingham MF
Can Anaesth Soc J; 1979 Jul; 26(4):319-21. PubMed ID: 509349
[TBL] [Abstract][Full Text] [Related]
14. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.
Brandom BW; Larach MG; Chen MS; Young MC
Anesth Analg; 2011 May; 112(5):1115-23. PubMed ID: 21372281
[TBL] [Abstract][Full Text] [Related]
15. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of an episode of malignant hyperthermia using a large dose of dantrolene.
Blank JW; Boggs SD
J Clin Anesth; 1993; 5(1):69-72. PubMed ID: 8442973
[TBL] [Abstract][Full Text] [Related]
17. [Suspected case of postoperative malignant hyperthermia treated with dantrolene one week after neurosurgery].
Itoh K; Nishibe S; Usuda Y; Kitamura A
Masui; 2014 Oct; 63(10):1153-5. PubMed ID: 25693350
[TBL] [Abstract][Full Text] [Related]
18. Special article: Creation of a guide for the transfer of care of the malignant hyperthermia patient from ambulatory surgery centers to receiving hospital facilities.
Larach MG; Dirksen SJ; Belani KG; Brandom BW; Metz KM; Policastro MA; Rosenberg H; Valedon A; Watson CB; ; ; ; ;
Anesth Analg; 2012 Jan; 114(1):94-100. PubMed ID: 22052978
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
Larach MG; Brandom BW; Allen GC; Gronert GA; Lehman EB
Anesth Analg; 2014 Dec; 119(6):1359-66. PubMed ID: 25268394
[TBL] [Abstract][Full Text] [Related]
20. Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia.
Ruhland G; Hinkle AJ
Anesthesiology; 1984 Feb; 60(2):159-60. PubMed ID: 6696240
[No Abstract] [Full Text] [Related]
[Next] [New Search]
